Providing safe, quality care for patients is our top priority, but we also strive to reduce the cost of healthcare. As an accountable care organization (ACO), WellSpan works with doctors, hospitals and other health care providers to improve the quality and experience of the care you receive.
ACOs receive a portion of any savings resulting from reducing costs and meeting quality requirements.
We're required to report information about our care and results. The following information is provided per Medicare Shared Savings Program (MSSP) regulations 42 CFR §425.308.
Public reporting information
ACO name and location
York Health Plan
601 Memory Lane
York, PA 17402
ACO primary contact
Brandon Danz, Vice President of Population Health
Phone number: 717-851-6649
Email address: WSHCustomerService@wellspan.org
Organizational information
| ACO participants
|
ACO participant in joint venture
(Yes or no)
|
| David Bene |
N |
| Premier Ankle & Foot Specialists, PC |
N |
| Lebanon Internal Medicine Associates, PC |
N |
| Dallastown Medical Associates, LLP |
N |
| Gettysburg Family Practice Inc. |
N |
| WellSpan Medical Group |
N |
| Hanover Family Practice Associates, LLC |
N |
| Apple Hill Podiatry Associates, PC |
N |
| Family First Health Corporation |
N |
| Lebanon Valley Family Medicine Inc. |
N |
| Schaefferstown Family Practice Inc. |
N |
| Keystone Rural Health Center |
N |
| Evangelical Medical Services Organization |
N |
ACO governing body
| Member
|
Member's voting power
|
Membership type
|
ACO participant TIN legal business name/DBA, if applicable
|
| Last name
|
First name
|
Title/position
|
| Dannehl |
William |
Chairman |
7.14% |
Community stakeholder |
N/A |
| Colli, MD |
Mike |
Vice Chairman |
7.14% |
ACO participant representative |
Keystone Rural Health Center |
| Aquilina, DO |
Anthony |
Voting Member |
7.14% |
ACO participant representative |
WellSpan Medical Group |
| Brown |
Richard |
Voting Member |
7.14% |
Medicare beneficiary |
N/A |
| Buczkowski |
Laura |
Voting Member |
7.14% |
ACO participant representative |
WellSpan Medical Group |
| Eisenberg, DO |
Maureen |
Voting Member |
7.14% |
ACO participant representative |
Hanover Family Practice Associates, LLC |
| Gasperack, DO |
David |
Voting Member |
7.14% |
ACO participant representative |
WellSpan Medical Group |
| Kerber, MD |
Ayn |
Voting Member |
7.14% |
ACO participant representative |
Evangelical Medical Services Organization |
| Klinedinst |
John |
Voting Member |
7.14% |
Community stakeholder |
N/A |
| Patel, MD |
Hetal |
Voting Member |
7.14% |
ACO participant representative |
Family First Health |
| Rao, MD |
G. Panisri |
Voting Member |
7.14% |
ACO participant representative |
WellSpan Medical Group |
| Rogers, MD |
Kenneth |
Voting Member |
7.14% |
ACO participant representative |
WellSpan Medical Group |
| Switaj, MD |
Timothy |
Voting Member |
7.14% |
ACO participant representative |
WellSpan Medical Group |
| Vega, MD |
David |
Voting Member |
7.14% |
ACO participant representative |
WellSpan Medical Group |
Due to rounding, "Member's voting power" may not equal 100%.
Key ACO clinical and administrative leadership
| Brandon Danz |
ACO Executive |
| Debra Bell, MD |
Medical Director |
| Wendy Trout |
Compliance Officer |
| Debra Bell, MD |
Quality Assurance/Improvement Officer |
Associated committees and committee leadership
| Committee name
|
Committee leader name and position
|
| Quality Committee |
Debra Bell, MD — Chair |
| Credentialing Committee |
Debra Bell, MD — Chair |
Types of ACO participants, or combinations of participants, that formed the ACO
- Networks of individual practices of ACO professionals
Shared savings and losses
Amount of shared savings and losses
- Fifth agreement period
- Performance year 2026: N/A
- Performance year 2025, N/A
- Fourth agreement period
- Performance year 2024: $27,077,295
- Third agreement period
- Performance year 2023: $12,133,445
- Performance year 2022, $16,115,023
- Second agreement period
- Performance year 2021, $0
- Performance year 2020, $0
- Performance year 2019, $0
- Performance year 2018, $0
- First agreement period
- Performance year 2017, $0
- Performance year 2016, $0
- Performance year 2015, $0
Shared savings distribution
Fifth agreement period
- Performance year 2026
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance year 2025
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Fourth agreement period
- Performance year 2024
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 100%
Third agreement period
- Performance year 2023
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 100%
- Performance year 2022
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 100%
Second agreement period
- Performance year 2021
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance year 2020
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance year 2019
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
First agreement period
- Performance year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance year 2016
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance year 2015
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
Quality performance results 2025
| Measure |
Measure Title |
Collection Type |
Performance Rate |
Current Year Mean Performance Rate (Shared Savings Program ACOs) |
| 321 |
CAHPS for MIPS |
CAHPS for MIPS Survey |
6.01 |
6.67 |
| 479* |
Hospital-Wide, 30-Day, AIl-Cause Unplanned Readmission (HWR) Rate for MIPS Groups |
Administrative Claims |
0.1485 |
0.1517 |
| 484* |
Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) |
Administrative Claims |
41.8 |
37 |
| 318 |
Falls: Screening for Future Fall Risk |
CMS Web Interface |
91.73 |
88.99 |
| 110 |
Preventative Care and Screening: Influenza Immunization |
CMS Web Interface |
82.87 |
68.6 |
| 226 |
Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention |
CMS Web Interface |
62.5 |
79.98 |
| 113 |
Colorectal Cancer Screening |
CMS Web Interface |
79.78 |
77.81 |
| 112 |
Breast Cancer Screening |
CMS Web Interface |
85.55 |
80.93 |
| 438 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
CMS Web Interface |
91.77 |
86.5 |
| 370 |
Depression Remission at Twelve Months |
CMS Web Interface |
4.69 |
17.35 |
| 001* |
Diabetes: Hemoglobin A1c (HbA1c) Poor Control |
CMS Web Interface |
7.14 |
9.44 |
| 134 |
Preventative Care and Screening: Screening for Depression and Follow-up Plan |
CMS Web Interface |
86.3 |
81.46 |
| 236 |
Controlling High Blood Pressure |
CMS Web Interface |
76.08 |
79.49 |
| CAHPS-1 |
Getting Timely Care, Appointments, and Information |
CAHPS for MIPS Survey |
84.97 |
83.7 |
| CAHPS-2 |
How Well Providers Communicate |
CAHPS for MIPS Survey |
93.86 |
93.96 |
| CAHPS-3 |
Patient's Rating of Provider |
CAHPS for MIPS Survey |
93.73 |
92.43 |
| CAHPS.4 |
Access to Specialists |
CAHPS for MIPS Survey |
69.69 |
75.76 |
| CAHPS-5 |
Health Promotion and Education |
CAHPS for MIPS Survey |
62.56 |
65.48 |
| CAHPS-6 |
Shared Decision Making |
CAHPS for MIPS Survey |
58.98 |
62.31 |
| CAHPS-7 |
Health Status and Functional Status |
CAHPS for MIPS Survey |
75.91 |
74.14 |
| CAHPS-8 |
Care Coordination |
CAHPS for MIPS Survey |
86.36 |
85.89 |
| CAHPS-9 |
Courteous and Helpful Office Staff |
CAHPS for MIPS Survey |
92 |
92.89 |
| CAHPS-11 |
Stewardship of Patient Resources |
CAHPS for MIPS Survey |
27.29 |
26.98 |
For previous years' financial and quality performance results, please visit data.cms.gov
*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs' providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.
Payment Rule Waivers
Skilled Nursing Facility (SNF) 3-Day Rule Waiver: Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612